chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On the day of injection my arm was severely sore, that didn?t happen on my first injection. On day 2, my arm was still sore but not as bad. I had a low grade fever (99.8 my normal temp is usually 96.7) with chills and an intense headache. I also felt fatigued. On day 3 the fever, chills and headache continued. By day 4, I was fine.
Diarrhea (persisting) Fatigue (persisting) Vomiting (resolved) Sore arm (resolved) Decreased stamina (persisting)
pt devel a 2 cm necrotic ulcer @ inj site p/vax (unk lot#);pt medical history is remarkable for COPD & HTN;no other info available;this case was reported by a MD;
Uncontrollable fussiness w/high ptiched cry lasting 3 hrs; no tx; no fever slept well p/cried for 3 hrs;
Patient began to have chest pain the day after 2nd dose of Moderna Vaccine.  Evaluation 28 Oct showed continued pain with troponin elevation.  She has sharp substernal chest pain as well as pain with breathing.
This spontaneous case reported by a consumer, describes the occurrence of asthma (series of asthma attacks) and ear pain (earache) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. January 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced asthma (series of asthma attacks) and ear pain (earache). At the time of the report, asthma (series of asthma attacks) and ear pain (earache) resolved. No concomitant product use provided. The patient treated with unspecified drugs in response to the events. Most recent follow-up information incorporated above included: On Jul 18, 2021: Follow-up received on Jul 18, 2021; no new information added.
Received the shot at 1:30 in the afternoon. Started feeling feverish and chilled by about 9:00 PM the same evening. Felt flu like symptoms for the following three days, with fever, aches, chills and fatigue. Chest pain started the day after the shot, and was intermittent, but recurring. Flu like symptoms came back a week after shot, with chest pain increasing in severity and becoming constant. 101 degree fever 9 days after shot prompted call to doctor for evaluation for chest pain and other symptoms. Primary doctor ran covid and flu tests (both negative) as well as EKG in office. Primary doctor encouraged me to go to ER for full cardiac evaluation
Patient received first dose Pfizer, second dose Moderna 3/26/2021. Counseled by Army Physician who supervises the EMT vaccinator.
I underwent arthroscopic surgery on my right knee on Tuesday May 11th. A few days later, I noticed pain increasing in my right calf. On Sunday morning (9:00 a.m.) I suffered a stroke. After being transported to Hospital, they discovered that I also had developed significant DVT in my right calf. This stroke occurred only 20 days after my 2nd Moderna vaccination. It's taken me a while to connect the dots, but considering my 4 prior knee surgeries did not result in any complications (including the prior surgery on the same knee in January of 2020), I suspect my clotting response was an overreaction to the knee surgery brought on by the vaccine.
At spot of injection, red and hot skin, sensitive to touch and clothing, swollen, sometimes itchy.
warm redness from her shoulder down to the elbow; redness from her shoulder down to the elbow; soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warm redness from her shoulder down to the elbow), VACCINATION SITE PAIN (soreness at the injection site) and VACCINATION SITE ERYTHEMA (redness from her shoulder down to the elbow) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037A21B and 038A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (NO RELEVANT HISTORY PROVIDED.).   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Apr-2021, the patient experienced VACCINATION SITE PAIN (soreness at the injection site). On 20-Apr-2021, the patient experienced VACCINATION SITE WARMTH (warm redness from her shoulder down to the elbow) and VACCINATION SITE ERYTHEMA (redness from her shoulder down to the elbow). At the time of the report, VACCINATION SITE WARMTH (warm redness from her shoulder down to the elbow), VACCINATION SITE PAIN (soreness at the injection site) and VACCINATION SITE ERYTHEMA (redness from her shoulder down to the elbow) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications included ice and acetaminophen.  There were no concomitant medications provided.
fatigue; felt like a semi hit her; This is a spontaneous report from a contactable other hcp. A female patient of an unspecified age received BNT162B2 (PFIZER BIONTECH COVID VACCINE, solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that after receiving the vaccine, nurse told her that she got symptoms seven days after getting the vaccine and she felt like a semi hit her. She stated that she didn't have a fever and neither did the caller. They just had fatigue. At the time of this report, the outcome of events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during fol-low up.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Rash & UrticariaPruritus Narrative:  Developed circular ~3x3 inch circular rash around the site of the injection 7 days after the vaccination. Rash persisted for 2 days prior to resolved and was described as pruritic, indurated, and erythematous. Not warm to touch. No therapies tried or applied. No hives, sloughing, or other adverse effects noted.
There are two names with same birthday system. At the time of healthcheck, the child in our office was in our office for a 5 yr HC and information that was printed was the wrong child and our office didn't realize it until after the vaccine were given. So the child in our office received a 3rd dose of Kinrix, MMR, and Varicella after the 2nd dose was given on 9/8/22. I have called and spoke with CDC about any potential reactions, and they assured there are likely no adverse reactions to occur.
This spontaneous report as received from a consumer refers to a 24 years old female patient. The patient was vaccinated with GARDASIL. No other co-suspects were reported. No concomitant medications were reported. On an unknown date the patient experienced become pregnant. No treatment information was reported. The outcome of become pregnant is unknown. The relatedness for becoming pregnant is unknown for GARDASIL. She indicated through the language line translator that she received the GARDASIL vaccination and has become pregnant. No further information is available. No further information is expected.
Woke up with severe nausea 5 days after vaccination. Thereafter, developed lower abdominal pain and constipation.  Took a dulcolax that relieved constipation. Then developed retching, vomiting and cramps abdominal pain
On January 25, 2022, I had an asthma attack while jumping rope in my home. By January 31,  my asthma symptoms worsened, and I sought emergency care at the Medical Clinic. I received an albuterol & atrovent nebulizer, a solumedrol IV, and was discharged with a 5 day course of prednisone (50mg) per day.  On February 2, I experienced tingling and edema in the lower legs and pain in the left side of my chest. I sought additional emergency care at Hospital.  The attending physician ordered an EKG, chest x-ray, blood test, and ultrasound of the legs. All tests were normal and I was dismissed after a few hours.
died since taking your COVID vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A patient (no qualifiers provided) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEATH (death, medically significant), outcome "fatal", described as "died since taking your COVID vaccine". The date and cause of death for the patient were unknown. It was not reported if an autopsy was performed. Reporter also reported that he/she has countless sick friends thanks to it. Stated that the clock was ticking, the truth will prevail.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202300020087 same reporter/drug/event, different patient.;; Reported Cause(s) of Death: died since taking your COVID vaccine
I am suddenly exhausted.; I am stressed; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 60 year-old patient received bnt162b2 (BNT162B2) (Lot number: EN6199) as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: AMLODIPINE; GLIPIZIDE; GABAPENTIN; ATORVASTATIN. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "I am suddenly exhausted."; STRESS (non-serious), outcome "unknown", described as "I am stressed".  No follow-up attempts are possible. No further information is expected.
Red, softball size red mark at injection/vaccine site (left arm); Cold chills, fever (felt hot); Migraine frontal - light sensitivity; Arm (left) hurts w/movement; Back pain - spine area (lower).
confluent red & pruritic maculopapular rash on the lower extremities & few red rash on the abdomen; t100.7 R;
itching; swelling; Allergic reaction; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pruritus in a patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis.   On 28-SEP-2023, the patient received RSV vaccine. On an unknown date, an unknown time after receiving RSV vaccine, the patient experienced pruritus (Verbatim: itching), swelling (Verbatim: swelling) and allergic reaction (Verbatim: Allergic reaction).  The patient was treated with benadryl (nos) (Benadryl). The outcome of the pruritus, swelling and allergic reaction were resolved (duration 1 week).   It was unknown if the reporter considered the pruritus, swelling and allergic reaction to be related to RSV vaccine.     It was unknown if the company considered the pruritus, swelling and allergic reaction to be related to RSV vaccine.   Additional Information: GSK Receipt date: 05-OCT-2023 This case was reported by patient via interactive digital media. A reporter reported that a patient had the RSV shot last Thursday and had itching and swelling for 1 week. The patient thought was an allergic reaction he/she need to know the ingredients and also benadyrl did not do anything to help the patient. Follow up was not possible, as no contact details were available.
Had gotten shot for shingles / Then shingle came on side of my neck/Suspected vaccination failure; Had gotten shot for shingles / Then shingle came on side of my neck; This case was reported by a consumer and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included COVID-19 VACCINE for prophylaxis.   On an unknown date, the patient received Shingrix and the 1st dose of COVID-19 VACCINE. On an unknown date, unknown after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix.  Additional details were provided as follows: The reporter was patient itself. The age at vaccination was not reported. The age group was not reported but was captured as per vaccine indication. The patient got shot for shingles before COVID 19 shot. Then shingle came on side of the patient's neck. The patient's 2nd COVID 19 vaccination was due on Monday and asked if the patient should take another Shingrix shot. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for target disease and laboratory confirmation were unknown at the time of reporting. It was unknown if the reporter considered shingles to be related to Covid-19 vaccine.
pt recv vax 17AUG92 & in 1996 pt was tested for titer & had failed to seroconvert;no further details were provided;
diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No Medical history has been reported.  Concomitant products included FLUVOXAMINE MALEATE (LUVOX), LAMOTRIGINE (LAMICTAL), OLANZAPINE (ZYPREXA), ATORVASTATIN, MELATONIN, NEBIVOLOL HYDROCHLORIDE (BYSTOLIC), LANSOPRAZOLE (PREVACID), TESTOSTERONE, FINASTERIDE (PROSCAR), TAMSULOSIN HYDROCHLORIDE (FLOMAX RELIEF), WARFARIN and TRAZODONE for an unknown indication.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced DIARRHOEA (diarrhea). At the time of the report, DIARRHOEA (diarrhea) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Weight decreased: decreased (Low) Decreased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication were not provided.
Pt complaining of pain, itching in upper left arm (underside).  Area is 10cmx8.5cm redness with swelling, warmth.  No other s/s present.  Pt to apply ice off/on, take Tylenol/Benadryl and come to clinic if changes.
heart was racing; Low grade fever of 101.4; nausea; headache; shivering; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 15-Mar-2021 and was forwarded to Moderna on 16-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (heart was racing), PYREXIA (Low grade fever of 101.4), NAUSEA (nausea), HEADACHE (headache) and CHILLS (shivering) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, the patient experienced TACHYCARDIA (heart was racing), PYREXIA (Low grade fever of 101.4), NAUSEA (nausea), HEADACHE (headache) and CHILLS (shivering). At the time of the report, TACHYCARDIA (heart was racing), PYREXIA (Low grade fever of 101.4), NAUSEA (nausea), HEADACHE (headache) and CHILLS (shivering) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No laboratory details were  provided.  Treatment medication include Tylenol.
Per telephone interview with patient, she received her 1st dose of Pfizer on 6/5/21 and her right arm got sore and very achy all the way down to her fingers. This went on for 3 days and then she felt "deathly ill," describing feeling hot, then cold, feverish, sweaty, stomach cramps, nausea, vomiting, diarrhea, and achy all over her body. The next day she had sore muscles and muscle spasms/cramps that occurred in her legs and back.  After receiving her 2nd dose of Pfizer on 7/6/21, her left arm became sore and achy again but not as bad as the first time. Her injection site did well slightly. The 3rd evening, she had stomach cramping, nausea, diarrhea, malaise, achy body, restless leg syndrome, and her midback ached and felt sore. She felt better the next day but her body was still achy.
19 yr old pregnant female, anxious about being vaccinated.  Moderna vaccination given Deltoid IM w/o issue.  Pt sent to OBS tent for 15 minutes post vaccine.  Pt's father with her.  Observer came to me to assess pt who stated she was dizzy.  VS taken Pulse 85, Resp 16, BP 96/64, pulse ox 98%.  Pt had already been given fruit and water.  Pt ?27 weeks pregnant; due October 15, 2021
INTERMITTENT L SIDED CHEST PAIN 2/10 IN SEVERITY. STABBING IN NATURE. DENIES RADIATION, DENIES NAUSEA/VOMITING, DENIES LIGHTHEADENESS PT REPORTED HAVING NEGATIVE CARDIAC WORK FOR A SIMILAR PRESENTATION AND REPORTS SX AT THAT TIME WERE ATTRIBUTED TO STRESS. REPORTS PMH ANXIETY VSS AND ASYMPTOMATIC AT D/C D/C VITALS : HR 57, RESP 18, BP 126/81, SPO2 100%
Vaccine was administered on 09/01/2022. Expiration date of vaccine was 08/26/2022. No adverse outcomes.
The patient developed low grade fevers 24 hours after his flu vaccine  and pfizer booster. Approx 48 hours after the vaccines, his fevers started spiking to tmax 103.7. He was treated at home until 12/26 with alternating ibuprofen and tylenol until 12/26 when, upon discussion with his primary care doc, me, he went to the ER. In ER noted to be hypotensive, tachycardic, and w fever. Also developed vomiting. Given fluids and ceftriaxone. Noted to have elevated troponin, crp, ldh. Normal chest xray. EKG with mild t wave abnormalities which resolved on second EKG. Normal bedside echo. Stabilized, sent to ICU for monitoring. Labs generally improved. Formal Echo normal. On 12/27 developed GI bleed w melanotic stool. sent for EGD and colonoscopy which showed possible mallory weiss tear/gastritis. Placed on protonix and received blood transfusion for drop of hemoglobin from 13 to 8. Advanced diet slowly.  Meanwhile ebv serology came back igm positive, heterophile neg. CMV igm also positive. NO EBV DNA found.  Patient stablized well with down trending troponins and inflammatory markers Hemoglobin stable able to eat and drink Discharged home on protonix and carafate on 12/30/21 Ultimately diagnosed with EBV and hyperinflammatory state. No Misc given self resolving fever and downtrending inflammation without treatement. No myocarditis given normal echo, ekgs, and normal cardiac MRI. It was felt that the elevated troponins were due to cross reactivity with EBV.
This spontaneous report as received from a nurse refers to a 17 year old patient. The reporter reported that the patient was inadvertently vaccinated with ZOSTAVAX (SQ, 0.65 ml) (lot# was unknown) on 10-OCT-2012. No adverse effect was reported. It was unspecified if the patient sought medical attention. Additional information is not expected.
Mom states pt lt leg turned purple w/several raised reddened areas on lower lt leg approx 5 hrs p/immun given; pt screamed constantly for approx 2 hrs @ same time; mom gave APAP w/some improvement; t99; fussy next day; sx gone by 6SEP91;
Patient tested positive for COVID with no symptoms.  Patient went to the ER for appendicitis and was tested before having an appendectomy.
I got a red spot on my arm two inches below the shot my arm was very painful. It was red swollen , painful and went away in two days. It came back about eight days after the shot. It was a baseball sized lump under the shot and it was more itchy and tender to touch. I went to the doctor they advised Advil, Ice and Benadryl. I tried those things and it went away after a few days. I got the second shot in the same arm, but I had no problems with my arm.
Patient noted to have some nausea. She remains alerts. No SOB noted. Skin u/d to touch. Respirations are even and non labored/ Patient assessed per this nurse and staff nurse. Increased monitoring x 15 minutes to amount to 30 minutes. V/S BP 94/62 P61 T97.6 R18 PO2 99% BG101. All safety measures maintained. No vomiting or emesis noted. Patient ambulated out of facility with steady gate at 1144AM
Information was received from a lawyer 08-AUG-2017 regarding a case in litigation concerning a plaintiff of unspecified age and gender. It was claimed the plaintiff was inoculated with ZOSTAVAX on or about 06-OCT-2009 at a Health unit, as recommended for routine adult health maintenance and for the prevention of shingles. It was claimed the vaccine did not prevent shingles as intended, but rather caused the plaintiff to contract a persistent strain of herpes zoster. On or about 07-AUG-2016 the plaintiff was treated by a physician at a hospital emergency department for the onset of a severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as herpes zoster, or shingles. The plaintiff had been prescribed acyclovir for management of the painful symptoms. As a direct and proximate result of these malfunctions, the plaintiff suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result, the plaintiff has suffered and will continue to suffer significant medical expenses, pain and suffering and other damages. Additional information was requested.
12MAy99 itchy, 3rd dose oral typhoid 13MAY99 hives;
Tremendous lower back pain.; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 03Apr2021 at 09:00 (at the age of 46-years-old) as single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. The patient did not take any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On 05Apr2021 at 09:00, the patient experienced tremendous lower back pain. The patient underwent lab test on 19Mar2021 which included SARS-CoV-2 test (nasal swab) and the result was negative. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of tremendous lower back pain which included purchasing of heating pad. The clinical outcome of tremendous lower back pain was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.